Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast‐phase myeloproliferative neoplasms. (10th June 2015) - Devillier, Raynier; Raffoux, Emmanuel; Rey, Jérôme; Lengline, Etienne; Ronchetti, Anne‐Marie; Sebert, Marie; Boissel, Nicolas; Robin, Marie; Vey, Norbert; Kiladjian, Jean‐Jacques; Dombret, Herve; Cluzeau, Thomas